Difference between revisions of "Part:BBa K5348032"

 
 
Line 1: Line 1:
  
−
__NOTOC__
+
 
 
<partinfo>BBa_K5348032 short</partinfo>
 
<partinfo>BBa_K5348032 short</partinfo>
  
Line 13: Line 13:
  
  
−
<!-- Uncomment this to enable Functional Parameter display
+
<html lang="en">
−
===Functional Parameters===
+
<head>
−
<partinfo>BBa_K5348032 parameters</partinfo>
+
    <meta charset="UTF-8">
−
<!-- -->
+
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
 +
    <title>pLEVI2.0 (BBa_K5348032)</title>
 +
    <style>
 +
        img {
 +
            max-width: 80%;
 +
            height: auto;
 +
        }
 +
        .caption {
 +
            text-align: center;
 +
            font-size: 0.9em;
 +
            margin-top: 5px;
 +
            margin-bottom: 20px;
 +
        }
 +
    </style>
 +
</head>
 +
<body>
 +
    <h2>Construction Design</h2>
 +
    <p>
 +
        This composite part consists of BBa_J23116 promotor, LEVI (BBa_K5348029), rrnB T1 terminator (BBa_B0015), CoIE promotor (BBa_K2244006), repressor cI (BBa_K327018), PR promotor (BBa_R0051), RBS(B0034), and pCDF-DUET-1-backbone (BBa_K5348031) which was constructed in <i>E. coli</i> DH5α strain.
 +
    </p>
 +
 
 +
    <h2>Engineering Principle</h2>
 +
    <p>
 +
        Under blue light irradiation, the LEVI domain undergoes a conformational change, forming a protein dimer. This dimer binds to its homologous operator sequence, inhibiting PColE promoter activity. Consequently, the cI repressor cannot be expressed, allowing the target protein to be expressed. In dark conditions, the PColE promoter initiates transcription and expression of the cI repressor, thereby inhibiting target gene transcription [1]. Additionally, we used the CloDF13 ori, a low-copy replication origin more suitable for constructing plasmids containing toxic genes. Our modified light-control system, LEVI2.0, is shown in Figure 1.
 +
    </p>
 +
 
 +
    <div style="text-align:center;">
 +
        <img src="https://static.igem.wiki/teams/5348/bba-k5348032/figure-1.jpg" alt="Figure 1. Schematic representation of the LEVI component and light control system">
 +
        <div class="caption">Figure 1. Schematic representation of the (A) LEVI component [1], and (B) LEVI-based light control system.</div>
 +
    </div>
 +
 
 +
    <h2>Experimental Approach</h2>
 +
    <p>
 +
        Using the pYC-pKC-pL plasmid as a template, we introduced BglII and EcoRV restriction sites upstream and downstream of the cI-rrnB_T1-PR fragment, obtaining a BglII-cI-rrnB_T1-PR-EcoRV fragment. Then, using this fragment and the synthesized plasmid pCDF-LEVIsemi-on as templates, we performed BglII and EcoRV double digestion. After obtaining the digested fragments and backbone, we used T4 ligase for ligation and transformed the ligation product into DH5α competent cells. Colony PCR and sequencing results confirmed the successful acquisition of the pLEVI2.0 plasmid (Figure 2).
 +
    </p>
 +
 
 +
    <div style="text-align:center;">
 +
        <img src="https://static.igem.wiki/teams/5348/bba-k5348032/figure-2.jpg" alt="Figure 2. Construction results of pLEVI2.0 plasmid">
 +
        <div class="caption">Figure 2. Construction results of pLEVI2.0 plasmid. (A) Design of pLEVI2.0 plasmid construction. (B-C) Amplification results of fragments with arrows indicating the correct bands. (D) Colony PCR results. (E) Sequencing results.</div>
 +
    </div>
 +
 
 +
    <h2>References</h2>
 +
    <p>[1] Chen, X., Liu, R., Ma, Z. et al. An extraordinary stringent and sensitive light-switchable gene expression system for bacterial cells. <i>Cell Res.</i> 2016, 26, 854–857.</p>
 +
 
 +
</body>
 +
</html>

Latest revision as of 14:30, 30 September 2024


pLEVI2.0

LEVI2.0 composite part insert into pCDFDuet dual expression vector

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NheI site found at 1332
    Illegal NheI site found at 3548
    Illegal NheI site found at 3571
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BglII site found at 71
    Illegal XhoI site found at 120
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal NgoMIV site found at 90
    Illegal NgoMIV site found at 585
    Illegal AgeI site found at 332
    Illegal AgeI site found at 4253
  • 1000
    COMPATIBLE WITH RFC[1000]


pLEVI2.0 (BBa_K5348032)

Construction Design

This composite part consists of BBa_J23116 promotor, LEVI (BBa_K5348029), rrnB T1 terminator (BBa_B0015), CoIE promotor (BBa_K2244006), repressor cI (BBa_K327018), PR promotor (BBa_R0051), RBS(B0034), and pCDF-DUET-1-backbone (BBa_K5348031) which was constructed in E. coli DH5α strain.

Engineering Principle

Under blue light irradiation, the LEVI domain undergoes a conformational change, forming a protein dimer. This dimer binds to its homologous operator sequence, inhibiting PColE promoter activity. Consequently, the cI repressor cannot be expressed, allowing the target protein to be expressed. In dark conditions, the PColE promoter initiates transcription and expression of the cI repressor, thereby inhibiting target gene transcription [1]. Additionally, we used the CloDF13 ori, a low-copy replication origin more suitable for constructing plasmids containing toxic genes. Our modified light-control system, LEVI2.0, is shown in Figure 1.

Figure 1. Schematic representation of the LEVI component and light control system
Figure 1. Schematic representation of the (A) LEVI component [1], and (B) LEVI-based light control system.

Experimental Approach

Using the pYC-pKC-pL plasmid as a template, we introduced BglII and EcoRV restriction sites upstream and downstream of the cI-rrnB_T1-PR fragment, obtaining a BglII-cI-rrnB_T1-PR-EcoRV fragment. Then, using this fragment and the synthesized plasmid pCDF-LEVIsemi-on as templates, we performed BglII and EcoRV double digestion. After obtaining the digested fragments and backbone, we used T4 ligase for ligation and transformed the ligation product into DH5α competent cells. Colony PCR and sequencing results confirmed the successful acquisition of the pLEVI2.0 plasmid (Figure 2).

Figure 2. Construction results of pLEVI2.0 plasmid
Figure 2. Construction results of pLEVI2.0 plasmid. (A) Design of pLEVI2.0 plasmid construction. (B-C) Amplification results of fragments with arrows indicating the correct bands. (D) Colony PCR results. (E) Sequencing results.

References

[1] Chen, X., Liu, R., Ma, Z. et al. An extraordinary stringent and sensitive light-switchable gene expression system for bacterial cells. Cell Res. 2016, 26, 854–857.